Nasal Polyposis Clinical Trials

29 clinical trials for Nasal Polyposis across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A DOUBLE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) WHO PARTICIPATED IN EITHER EFC18418 OR EFC18419 CLINICAL STUDIES — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3 TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS — RECRUITING · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3 TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS — RECRUITING · PHASE3
• A MULTICENTRE, SINGLE-ARM, PHASE 3B STUDY TO ASSESS CHANGES IN SYMPTOMS IN ADULT PARTICIPANTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS INITIATING TREATMENT WITH TEZEPELUMAB (ESSENCE) — RECRUITING · PHASE3
• A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB/LY3650150 IN ADULT PARTICIPANTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS ON BACKGROUND INTRANASAL CORTICOSTEROIDS — RECRUITING · PHASE3
• A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED PHASE 3 EFFICACY AND SAFETY STUDY OF TEZEPELUMAB IN PARTICIPANTS WITH SEVERE CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (WAYPOINT) — RECRUITING · PHASE3
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY OF FEVIPIPRANT ONCE DAILY PLUS STANDARD-OF-CARE (SOC) FOR ASSESSMENT OF THE EFFICACY IN REDUCTION OF NASAL POLYPS SIZE IN PATIENTS WITH NASAL POLYPOSIS AND CONCOMITANT ASTHMA — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, 52-WEEK, PLACEBO CONTROLLED EFFICACY AND SAFETY STUDY OF DUPILUMAB, IN PATIENTS WITH BILATERAL NASAL POLYPOSIS ON A BACKGROUND THERAPY WITH INTRANASAL CORTICOSTEROIDS — RECRUITING
• Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID) — TERMINATED · PHASE3
• Long-term Effect of Dupilumab in N-ERD — NOT_YET_RECRUITING
• Development of a Severity Assessment Score for Nasosinus Polyposis (PSI Score) — COMPLETED
• Nasality Evolution in a Nasal Polyposis Context : Multiparametric Evaluation : Articulatory (Imaging), Aerodynamics, Acoustics and Perception — OTHER
• Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis — COMPLETED · PHASE2
• Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis — COMPLETED · PHASE3
• Study to Evaluate Multiple Doses in Patients With Nasal Polyposis — COMPLETED · PHASE2
• Smell Exploration in Patients With Nasal Polyposis : Study by Functional Magnetic Resonance Imaging — OTHER · NA
• Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis — COMPLETED · PHASE2
• Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video — COMPLETED · PHASE3
• A MULTICENTRE, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED PHASE 3 EFFICACY AND SAFETY STUDY OF BENRALIZUMAB FOR THE PREVENTION OF RECURRENCE OF NASAL POLYPS FOLLOWING SURGICAL REMOVAL IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (OXALIS) — NOT_YET_RECRUITING · PHASE3
• Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE) — COMPLETED · PHASE3
• The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery — COMPLETED · NA
• S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps — COMPLETED · PHASE3
• OPEN-LABEL EXTENSION STUDY OF OMALIZUMAB IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS — COMPLETED
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED PHASE 3 EFFICACY AND SAFETY STUDY OF BENRALIZUMAB IN PATIENTS WITH SEVERE NASAL POLYPOSIS (OSTRO) — COMPLETED · PHASE3
• ÉTUDE RANDOMISÉE CONTRÔLÉE À SIMPLE INSU COMPARANT LE TRAITEMENT PAR CORTICOSTÉROÏDES INTRANASAUX EN VAPORISATEUR OU EN IRRIGATION CHEZ LES PATIENTS AVEC RHINOSINUSITE CHRONIQUE ET POLYPOSE NASALE — NOT_YET_RECRUITING
• A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHIII STUDY TO ASSESS THE CLINICAL EFFICACY AND SAFETY OF 100 MG SC MEPOLIZUMAB AS AN ADD ON TO MAINTENANCE TREATMENT IN ADULTS WITH SEVERE BILATERAL NASAL POLYPS — COMPLETED
• The Effect of RF Turbinoplasty in Polypoid Change of Middle Turbinates — OTHER · PHASE3
• Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma — COMPLETED · PHASE2
• Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis — COMPLETED · PHASE2

Refine this search